Tower Research Capital (TRC)’s QuidelOrtho QDEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $98.1K | Buy |
5,973
+3,827
| +178% | +$94K | ﹤0.01% | 2206 |
|
|
2025
Q4 | $61.3K | Sell |
2,146
-977
| -31% | -$26.5K | ﹤0.01% | 2277 |
|
|
2025
Q3 | $92K | Sell |
3,123
-2,174
| -41% | -$59.4K | ﹤0.01% | 2058 |
|
|
2025
Q2 | $153K | Buy |
5,297
+4,727
| +829% | +$140K | ﹤0.01% | 2033 |
|
|
2025
Q1 | $19.9K | Buy |
570
+174
| +44% | +$7.1K | ﹤0.01% | 2975 |
|
|
2024
Q4 | $17.6K | Sell |
396
-2,401
| -86% | -$98.2K | ﹤0.01% | 3295 |
|
|
2024
Q3 | $128K | Sell |
2,797
-78,020
| -97% | -$3.16M | ﹤0.01% | 2035 |
|
|
2024
Q2 | $2.68M | Buy |
80,817
+77,700
| +2,493% | +$3.18M | 0.05% | 339 |
|
|
2024
Q1 | $149K | Sell |
3,117
-9,245
| -75% | -$539K | ﹤0.01% | 1597 |
|
|
2023
Q4 | $911K | Buy |
12,362
+10,137
| +456% | +$685K | 0.01% | 913 |
|
|
2023
Q3 | $163K | Sell |
2,225
-11,436
| -84% | -$913K | 0.01% | 1577 |
|
|
2023
Q2 | $1.13M | Buy |
13,661
+11,600
| +563% | +$1.02M | 0.04% | 439 |
|
|
2023
Q1 | $184K | Sell |
2,061
-768
| -27% | -$66.8K | 0.01% | 1415 |
|
|
2022
Q4 | $243K | Buy |
2,829
+595
| +27% | +$50.4K | 0.01% | 1182 |
|
|
2022
Q3 | $160K | Sell |
2,234
-8,756
| -80% | -$783K | ﹤0.01% | 2140 |
|
|
2022
Q2 | $1.07M | Buy |
10,990
+2,824
| +35% | +$288K | 0.02% | 649 |
|
|
2022
Q1 | $919K | Buy |
8,166
+2,704
| +50% | +$288K | 0.01% | 825 |
|
|
2021
Q4 | $738K | Buy |
5,462
+3,317
| +155% | +$462K | 0.01% | 870 |
|
|
2021
Q3 | $303K | Sell |
2,145
-310
| -13% | -$41.7K | 0.01% | 1398 |
|
|
2021
Q2 | $315K | Sell |
2,455
-2,348
| -49% | -$276K | 0.01% | 1568 |
|
|
2021
Q1 | $614K | Buy |
4,803
+2,352
| +96% | +$434K | 0.01% | 1067 |
|
|
2020
Q4 | $440K | Sell |
2,451
-3,622
| -60% | -$805K | 0.01% | 1089 |
|
|
2020
Q3 | $1.33M | Sell |
6,073
-1,772
| -23% | -$395K | 0.01% | 710 |
|
|
2020
Q2 | $1.76M | Buy |
+7,845
| New | +$1.23M | 0.07% | 267 |
|
|
2019
Q4 | – | Sell |
-49
| Closed | -$3K | – | 4211 |
|
|
2019
Q3 | $3K | Sell |
49
-540
| -92% | -$32.5K | ﹤0.01% | 3581 |
|
|
2019
Q2 | $35K | Buy |
589
+386
| +190% | +$23.2K | ﹤0.01% | 1815 |
|
|
2019
Q1 | $13K | Buy |
+203
| New | +$12.3K | ﹤0.01% | 2535 |
|
|
2018
Q3 | – | Sell |
-39
| Closed | -$3K | – | 4158 |
|
|
2018
Q2 | $3K | Buy |
+39
| New | +$2.36K | ﹤0.01% | 3248 |
|
|
2018
Q1 | – | Sell |
-199
| Closed | -$9K | – | 3724 |
|
|
2017
Q4 | $9K | Sell |
199
-1,092
| -85% | -$44.6K | ﹤0.01% | 2619 |
|
|
2017
Q3 | $57K | Buy |
+1,291
| New | +$44.9K | ﹤0.01% | 1841 |
|
|
2017
Q1 | – | Sell |
-100
| Closed | -$2K | – | 3745 |
|
|
2016
Q4 | $2K | Sell |
100
-1,813
| -95% | -$38.9K | ﹤0.01% | 3449 |
|
|
2016
Q3 | $42K | Buy |
1,913
+345
| +22% | +$7.37K | ﹤0.01% | 1237 |
|
|
2016
Q2 | $28K | Buy |
+1,568
| New | +$27.1K | ﹤0.01% | 1979 |
|
|
2015
Q4 | – | Sell |
-3,267
| Closed | -$62K | – | 4942 |
|
|
2015
Q3 | $62K | Buy |
3,267
+589
| +22% | +$12.6K | 0.01% | 872 |
|
|
2015
Q2 | $61K | Buy |
+2,678
| New | +$62.4K | 0.01% | 1210 |
|
|
2015
Q1 | – | Sell |
-3,337
| Closed | -$97K | – | 4825 |
|
|
2014
Q4 | $97K | Buy |
3,337
+2,464
| +282% | +$66.8K | 0.01% | 683 |
|
|
2014
Q3 | $23K | Buy |
873
+440
| +102% | +$10.5K | ﹤0.01% | 2190 |
|
|
2014
Q2 | $9K | Sell |
433
-24
| -5% | -$552 | ﹤0.01% | 2450 |
|
|
2014
Q1 | $12K | Sell |
457
-259
| -36% | -$7.56K | ﹤0.01% | 2437 |
|
|
2013
Q4 | $22K | Sell |
716
-141
| -16% | -$3.62K | ﹤0.01% | 2227 |
|
|
2013
Q3 | $24K | Buy |
+857
| New | +$23.4K | ﹤0.01% | 2544 |
|
Other funds holding QDEL
NM
VPM
RCMNY
VCM
Tower Research Capital (TRC)'s QDEL Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its QuidelOrtho (QDEL) stake by 178% in Q1 2026, buying an estimated $94K and bringing the position to 5,973 shares worth $98.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.
Tower Research Capital (TRC) first reported a position in QDEL in Q3 2013 and has held it in 41 quarters since. The position peaked at $2.68M in Q2 2024. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.
- Tower Research Capital (TRC) held 5,973 shares of QuidelOrtho worth $98.1K as of Q1 2026.
- Tower Research Capital (TRC) bought 3,827 QuidelOrtho shares in Q1 2026, an estimated $94K.
- QuidelOrtho made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2206 holding.
- Tower Research Capital (TRC) first reported a position in QuidelOrtho in Q3 2013 and has held it in 41 quarters since.
- Tower Research Capital (TRC)'s QuidelOrtho position peaked at $2.68M in Q2 2024.
- 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.